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The beneﬁcial effects of medium-chain fatty acids on metabolism
and oxidative stress
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Dietary intake of long-chain fatty acids (LCFA, CN16) plays a
causative role in insulin resistance and risk of diabetes. Whereas
LCFA promote lipid accumulation and have detrimental effects on
metabolic health, diets rich in medium-chain fatty acids (MCFA; C8–
C14) have been associated with increased oxidative metabolism and
reduced adiposity, with little effect on insulin action in vivo. The
molecular mechanisms underlying these differences are poorly under-
stood. To shed light into this question, we have treated L6 myotubes
with speciﬁc MCFA (capric acid, 10:0 and lauric acid, 12:0) and LCFA
(palmitic acid, 16:0 and oleic acid, 18:1) and determined the effect of
fatty acid treatment on metabolic parameters including triglyceride
accumulation and insulin-stimulated glycogen synthesis as a measure
of insulin sensitivity. A potential mechanism linking lipid accumulation
and insulin resistance is increased oxidative stress within the insulin-
sensitive tissue. Therefore, these studies were extended by measuring
reactive oxygen species (ROS) production and oxidative damage in
muscle cells treated with different fatty acids.
Incubation of myotubes with LCFA led to lipid accumulation
(+90% with palmitic acid vs. control BSA-treated cells, pb0.01),
impaired glycogen synthesis (−40%, pb0.05) and decreased succi-
nate dehydrogenase activity (−40–55% vs. control, pb0.05), however
these deleterious effects were not observed in the MCFA-treated
myotubes. Furthermore, ROS generation (both superoxide and
hydrogen peroxide), measured using HPLC and spectrophotometry,
was not signiﬁcantly altered with MCFA, but was signiﬁcantly greater
in the LCFA-treated cells (+500% vs. control, pb0.001), suggesting
that MCFA might prevent the induction of oxidative stress. Increased
oxidative stress with LCFA, but not MCFA, was conﬁrmed by
measuring a marker of lipoxidative damage, lipid hydroperoxides,
which were increased by LCFA (+40% vs. control, pb0.01), but
remained unchanged in the MCFA-treated cells.
These results show that treatment of muscle cells with MCFA does
not produce the detrimental metabolic effects observed when cells
are exposed to LCFA. A potential mechanism is the differential effects
observed in ROS production and oxidative damage in the MCFA- and
LCFA-treated L6 myotubes.
doi:10.1016/j.bbabio.2012.06.327
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Obesity generates metabolic alterations in the myocardium
leading to changes in mitochondrial membrane permeability
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Obesity is a chronic disease of multifactorial origin, characterized
by an excessive accumulation of fat that generates multiple metabolic
disorders leading to cardiovascular diseases (concentric cardiac
hypertrophy, hypertension, atherosclerosis and heat failure), diabetes
mellitus type 2, among others. High lipid accumulation has been
found in the heart of obese rats and humans1, and in addition it has
been described that the apoptotic signaling pathway is active in
hearts from obese patients2. Apoptotic cell death involves several
mechanisms; one of them is the mitochondrial permeability transi-
tion (MPT), phenomenon that is activated by ionic deregulation and
high production of reactive oxygen species (ROS). In this work we
have evaluated the mechanism by which the MPT apoptotic pathway
is activated in hearts from obese rats (mOb).
The results show that mitochondria from mOb were 2.5 and 3
times more susceptible to MPT than mitochondria from Lean rats
(mLean) when the respiratory chain was supplemented with
Glutamate–Malate (GM) or Glutamate–Succinate (GS). However, this
effect was not observed in the presence of Succinate-rotenone, as
substrate. In all experimental conditions, cyclosporine A (CSA)
protected the mitochondria, therefore, suggesting that the main
mechanism involved in the MPT is the high ROS production. Since the
NADH dehydrogenase is one of the enzymes that generate ROS, and,
under conditions of GS, the succinate dehydrogenase generates even
more ROS3, we analyzed the oxidative stress, ﬁnding higher
production of H2O2 in mOb than in mLean, mainly when the substrate
was GS. On the other hand, when the MPT was induced with
carboxiatractyloside (CAT), an inhibitor of the adenine nucleotide
translocase (ANT), the susceptibility to MPT was higher in mOb than
mLean, using GM as substrate and in the presence of CAT 1.5 μM, and
even more susceptible in the presence of GS and CAT 0.4 μM. Probably
because ROS is higher in mOb, and they may induce conformational
changes in mitochondrial proteins, increasing the binding of CAT and
accelerating the MPT. Finally, mitochondrial integrity was evaluated
by measuring respiration, and the results show that the respiratory
control and oxygen consumption in state 3 was lower in mOb; the
effect was observed only in the presence of GM. These results suggest
that ATP synthesis might be impaired due to decreased membrane
potential in mOb and contributes to MPT sensitivity. Conclusion: The
mOb has a higher sensibility to MPT than mLean and the principal
mechanism involved is the ROS production.
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During growth of solid tumors, gradients of oxygen and nutrients
develop inducing speciﬁc metabolic changes in the proliferative and
quiescent cellular layers. An integral analysis of proteomics, met-
abolomics, kinetomics and ﬂuxomics revealed that both enrich-
proliferative (PRL) and ‐quiescent (QS) cellular layers of mature
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human breast tumor MCF-7 multi-cellular spheroids maintained
similar glycolytic rates (3-5 nmol/min/106 cells), which correlated
with similar protein contents (GLUT1, GLUT3, HKII, and LDH-A) and
enzyme activities (HK and LDH). Enhanced glycolytic ﬂuxes in both
cell layer fractions also correlated with higher expression of the
transcriptional factors HIF-1a and TIGAR compared to MCF-7
monolayer cultures. On the contrary, the contents of the mitochon-
drial proteins ND1, SDH, COXIV, PDH, 2-OGDH, glutaminase, and ATP
synthase (3-20 times) as well as the respiratory chain enzyme
activities (COX, SDH) and the oxidative phosphorylation (OxPhos)
ﬂux (2-times) were higher in PRL vs. QS. Enhanced mitochondrial
metabolism in the PRL layers correlated with an increase in the
oncogenes h-Ras and c-Myc, and transcription factors p32 and PGC-
1α involved in the OxPhos activation. On the other hand, the lower
mitochondrial function in the QS layers was associated with an
increase in Atg7, Beclin, LC3B, Bnip3 and LAMP protein levels
indicating active mitophagy and lysosome biosynthesis. Although a
substantial increase in glycolysis was developed, OxPhos was the
main ATP supplier in both QS and PRL cell layers. Therefore, anti-
mitochondrial therapy by using oligomycin or Casiopeina II-gly was
effective to arrest MCF-7 spheroid growth (IC50≈20–25 nM)
without apparent effect on normal epithelial breast tissue at similar
doses; canonical anti-neoplastic drugs such as cisplatin and tamox-
ifen were signiﬁcantly less potent.
doi:10.1016/j.bbabio.2012.06.329
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Measuring mitochondrial dysfunction is increasingly important in
the study of neurodegenerative and cardiovascular diseases, meta-
bolic syndrome, diabetes, cancer, and aging. Mitochondrial function is
usually measured by oxygen consumption rates using respirometry
methods. However, a critical aspect of mitochondrial function may be
overlooked when only O2 consumption is employed: the tricarboxylic
acid (TCA) or Krebs cycle, a central metabolic pathway. Measuring the
TCA cycle function requires monitoring the ﬂux of an additional
analyte, such as carbon dioxide (CO2). The reported method describes
simultaneous monitoring of carbon dioxide evolution rates (CDER)
and oxygen consumption rates (OCR) using isolated mitochondria
and intact cells, in real-time, using the XF24-3 Analyzer. This
technology employs ﬂuorescent sensors speciﬁc for CO2 and O2,
which operate reversibly, and reveal details of mitochondrial
respiration and the TCA cycle. Results indicate that O2 consumption
and CO2 evolution may be monitored simultaneously, and that data
agrees with attributes of TCA cycle and mitochondrial function
obtained by other methods. Differential rates of O2 and CO2 ﬂux can
be identiﬁed, relative to substrate utilization and interdependency
among the TCA cycle, electron transport, and oxidative phosphory-
lation systems.
doi:10.1016/j.bbabio.2012.06.330
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The still rising prevalence of obesity stimulates intensive research on
white adipose tissue biology in diet-induced or genetically obese mice
as model organisms. Studies on obesity and its common co-morbidities
indicate a so far underestimated relevance of mitochondria for both
white adipocyte function as well as whole body energy balance
regulation. Protocols for the bioenergetic analysis of mitochondria
isolated from white adipocytes using state of the art respirometry
technology are lacking. White adipose tissue is only equipped with a
low respiratory capacity and it is a complex and dynamic tissue
consisting of multiple cell types such as endothelial cells, pericytes,
ﬁbroblasts, preadipocytes, mature adipocytes and macrophages. The
main challenge is to isolate intactmitochondria frommature adipocytes
in quantities sufﬁcient for comprehensive bioenergetic analyses.
We established a new protocol for the isolation of intact mitochon-
dria frommurinewhite adipocytes suitable for high throughput 96-well
microplate respirometry. Therewith substrate speciﬁc bioenergetic
proﬁles including basal respiration, ATP turnover, proton leak and
maximal respiration rates as the key parameters of mitochondrial
function can bemeasured. This new technology will be applicable to A)
elucidate regional differences in mitochondrial function in adipocytes
isolated from different adipose tissue depots, B) to study the potential
inﬂuence of genetic and dietary manipulations of body adiposity on
mitochondrial function in adipocytes and C) to identify adipocyte
speciﬁc mitochondrial proteins.
doi:10.1016/j.bbabio.2012.06.331
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Recent data supports the cancer stem cell (CSC) theory accounting
for their ability to evade chemotherapy resulting in tumor regrowth [1].
Our objective is to ﬁndmitochondrial and overall metabolic differences
which can explain selective CSC survival. P19 embryonal CSC and
retinoic acid-differentiated cells (dCC) were used. Metabolic proﬁles
were evaluated by 13C isotopomer analysis using 1H nuclear magnetic
resonance showing increased lactate production on CSC. dCC NMR
spectra show a more complex metabolic proﬁle. Mitochondrial
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